{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:07:41Z","timestamp":1789168061914,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007380","name":"Fondation de l'Avenir pour la Recherche M\u00e9dicale Appliqu\u00e9e","doi-asserted-by":"publisher","award":["AP-RM-23-007"],"award-info":[{"award-number":["AP-RM-23-007"]}],"id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010777","name":"Agence Nationale de la Recherche - Program \"Emergence\"","doi-asserted-by":"publisher","award":["ANR\u201018\u2010IdEx\u20100001"],"award-info":[{"award-number":["ANR\u201018\u2010IdEx\u20100001"]}],"id":[{"id":"10.13039\/501100010777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Haematological malignancies (HMs) are characterized by profound immune dysregulation, which increases susceptibility to sepsis. This dysregulation arises from the underlying disease and may be exacerbated by treatments. Sepsis itself induces a biphasic immune response, with an initial hyperinflammatory phase followed by prolonged immunosuppression that can persist for months or years, potentially impacting the course of HMs. This review examines the reciprocal interactions between HMs and sepsis, focusing on innate and adaptive immune alterations, the influence of malignancy-associated dysbiosis, and insights gained from experimental models. In addition, we discuss how sepsis-induced systemic inflammation may influence the progression of the underlying malignancy, through pro-inflammatory cytokine signaling and alterations in the bone marrow microenvironment. Understanding these complex interactions may provide a framework for mitigating infection-related complications and for exploring their influence on the natural history and progression of HM.<\/jats:p>","DOI":"10.1186\/s40635-026-00904-6","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:29:29Z","timestamp":1777357769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune interplay between sepsis and haematological malignancies"],"prefix":"10.1186","volume":"14","author":[{"given":"St\u00e9phanie","family":"Pons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Touze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-3116","authenticated-orcid":false,"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"904_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0323-4","volume":"10","author":"D Pulte","year":"2020","unstructured":"Pulte D, Jansen L, Brenner H (2020) Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century. Blood Cancer J 10:56. https:\/\/doi.org\/10.1038\/s41408-020-0323-4","journal-title":"Blood Cancer J"},{"key":"904_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3324\/haematol.2010.031583","volume":"96","author":"P Schellongowski","year":"2011","unstructured":"Schellongowski P, Staudinger T, Kundi M et al (2011) Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 96:231\u2013237. https:\/\/doi.org\/10.3324\/haematol.2010.031583","journal-title":"Haematologica"},{"key":"904_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","volume":"45","author":"M Darmon","year":"2019","unstructured":"Darmon M, Bourmaud A, Georges Q et al (2019) Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45:977\u2013987. https:\/\/doi.org\/10.1007\/s00134-019-05653-7","journal-title":"Intensive Care Med"},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/CCM.0000000000004322","volume":"48","author":"V Lemiale","year":"2020","unstructured":"Lemiale V, Pons S, Mirouse A et al (2020) Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique Study*. Crit Care Med 48:822\u2013829. https:\/\/doi.org\/10.1097\/CCM.0000000000004322","journal-title":"Crit Care Med"},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","volume":"47","author":"BL Ferreyro","year":"2021","unstructured":"Ferreyro BL, Scales DC, Wunsch H et al (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47:1104\u20131114. https:\/\/doi.org\/10.1007\/s00134-021-06502-2","journal-title":"Intensive Care Med"},{"key":"904_CR7","first-page":"1","volume-title":"Handbook of Cancer and Immunology","author":"O Garrone","year":"2022","unstructured":"Garrone O, Denaro N, Paccagnella M et al (2022) Immunological Effects of Conventional Anticancer Drugs. In: Rezaei N (ed) Handbook of Cancer and Immunology. Springer International Publishing, Cham, pp 1\u201313"},{"key":"904_CR8","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-4750","volume":"9","author":"N Okwundu","year":"2021","unstructured":"Okwundu N, Grossman D, Hu-Lieskovan S et al (2021) The dark side of immunotherapy. Ann Transl Med 9:1041. https:\/\/doi.org\/10.21037\/atm-20-4750","journal-title":"Ann Transl Med"},{"key":"904_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2024028199","volume":"146","author":"P Goel","year":"2025","unstructured":"Goel P, Aryal S, Franceski AM et al (2025) The acute myeloid leukemia microenvironment impairs neutrophil maturation and function through NF-\u03baB signaling. Blood 146:1707\u20131721. https:\/\/doi.org\/10.1182\/blood.2024028199","journal-title":"Blood"},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1182\/blood-2018-99-112204","volume":"132","author":"MU Mushtaq","year":"2018","unstructured":"Mushtaq MU, Chaudhary SG, Guru Murthy GS et al (2018) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Relapsed\/Refractory Acute Myeloid Leukemia. Blood 132:5246\u20135246. https:\/\/doi.org\/10.1182\/blood-2018-99-112204","journal-title":"Blood"},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1200\/JCO.19.01937","volume":"38","author":"T Shree","year":"2020","unstructured":"Shree T, Li Q, Glaser SL et al (2020) Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma. J Clin Oncol 38:1664\u20131675. https:\/\/doi.org\/10.1200\/JCO.19.01937","journal-title":"J Clin Oncol"},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1182\/blood.2024027877","volume":"146","author":"RJ Pelzl","year":"2025","unstructured":"Pelzl RJ, Benintende G, Gsottberger F et al (2025) Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment. Blood 146:1300\u20131313. https:\/\/doi.org\/10.1182\/blood.2024027877","journal-title":"Blood"},{"key":"904_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1393599","volume":"7","author":"SJ McKee","year":"2018","unstructured":"McKee SJ, Tuong ZK, Kobayashi T et al (2018) B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity. OncoImmunology 7:e1393599. https:\/\/doi.org\/10.1080\/2162402X.2017.1393599","journal-title":"OncoImmunology"},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1111\/jcmm.17576","volume":"26","author":"P Peterlin","year":"2022","unstructured":"Peterlin P, Debord C, Eveillard M et al (2022) Peripheral levels of monocytic myeloid\u2010derived suppressive cells before and after first induction predict relapse and survivals in AML patients. J Cell Mol Med 26:5486\u20135492. https:\/\/doi.org\/10.1111\/jcmm.17576","journal-title":"J Cell Mol Med"},{"key":"904_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7363084","volume":"2020","author":"H Wang","year":"2020","unstructured":"Wang H, Tao Q, Wang Z et al (2020) Circulating monocytic myeloid\u2010derived suppressor cells are elevated and associated with poor prognosis in acute myeloid leukemia. J Immunol Res 2020:7363084. https:\/\/doi.org\/10.1155\/2020\/7363084","journal-title":"J Immunol Res"},{"key":"904_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081768","volume":"10","author":"Z Wang","year":"2021","unstructured":"Wang Z, Jiang R, Li Q et al (2021) Elevated M-MDSCs in circulation are indicative of poor prognosis in diffuse large B-cell lymphoma patients. J Clin Med 10:1768. https:\/\/doi.org\/10.3390\/jcm10081768","journal-title":"J Clin Med"},{"key":"904_CR17","doi-asserted-by":"publisher","first-page":"27676","DOI":"10.18632\/oncotarget.8507","volume":"7","author":"O Marini","year":"2016","unstructured":"Marini O, Spina C, Mimiola E et al (2016) Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. Oncotarget 7:27676\u201327688. https:\/\/doi.org\/10.18632\/oncotarget.8507","journal-title":"Oncotarget"},{"key":"904_CR18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/eji.202049141","volume":"51","author":"M De Zuani","year":"2021","unstructured":"De Zuani M, Hortov\u00e1\u2010Kohoutkov\u00e1 M, Andrej\u010dinov\u00e1 I et al (2021) Human myeloid\u2010derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data. Eur J Immunol 51:1785\u20131791. https:\/\/doi.org\/10.1002\/eji.202049141","journal-title":"Eur J Immunol"},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","volume":"196","author":"F Uhel","year":"2017","unstructured":"Uhel F, Azzaoui I, Gr\u00e9goire M et al (2017) Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis. Am J Respir Crit Care Med 196:315\u2013327. https:\/\/doi.org\/10.1164\/rccm.201606-1143OC","journal-title":"Am J Respir Crit Care Med"},{"key":"904_CR20","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1182\/bloodadvances.2024013073","volume":"8","author":"JD Soumerai","year":"2024","unstructured":"Soumerai JD, Yousif Z, Gift T et al (2024) IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence. Blood Adv 8:4239\u20134249. https:\/\/doi.org\/10.1182\/bloodadvances.2024013073","journal-title":"Blood Adv"},{"key":"904_CR21","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.ccell.2025.07.023","volume":"43","author":"RS Hesterberg","year":"2025","unstructured":"Hesterberg RS, Davis JT, Handoo KJ et al (2025) Lymphoma accelerates T cell and tissue aging. Cancer Cell 43:1917-1936.e8. https:\/\/doi.org\/10.1016\/j.ccell.2025.07.023","journal-title":"Cancer Cell"},{"key":"904_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/microorganisms12040775","volume":"12","author":"E Quiros-Roldan","year":"2024","unstructured":"Quiros-Roldan E, Sottini A, Natali PG, Imberti L (2024) The impact of immune system aging on infectious diseases. Microorganisms 12:775. https:\/\/doi.org\/10.3390\/microorganisms12040775","journal-title":"Microorganisms"},{"key":"904_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00480-0","author":"A Lasry","year":"2022","unstructured":"Lasry A, Nadorp B, Fornerod M et al (2022) An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. https:\/\/doi.org\/10.1038\/s43018-022-00480-0","journal-title":"Nat Cancer"},{"key":"904_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imm.12237","volume":"142","author":"K Bhattacharya","year":"2014","unstructured":"Bhattacharya K, Chandra S, Mandal C (2014) Critical stoichiometric ratio of CD 4+ CD 25+ FoxP3+ regulatory T cells and CD 4+ CD 25\u2212 responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Immunology 142:124\u2013139. https:\/\/doi.org\/10.1111\/imm.12237","journal-title":"Immunology"},{"key":"904_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42652-6","volume":"9","author":"A Rashidi","year":"2019","unstructured":"Rashidi A, Kaiser T, Shields-Cutler R et al (2019) Dysbiosis patterns during re-induction\/salvage versus induction chemotherapy for acute leukemia. Sci Rep 9:6083. https:\/\/doi.org\/10.1038\/s41598-019-42652-6","journal-title":"Sci Rep"},{"key":"904_CR26","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/2211-5463.13193","volume":"11","author":"D Yu","year":"2021","unstructured":"Yu D, Yu X, Ye A et al (2021) Profiling of gut microbial dysbiosis in adults with myeloid leukemia. FEBS Open Bio 11:2050\u20132059. https:\/\/doi.org\/10.1002\/2211-5463.13193","journal-title":"FEBS Open Bio"},{"key":"904_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236460","volume":"15","author":"T Rattanathammethee","year":"2020","unstructured":"Rattanathammethee T, Tuitemwong P, Thiennimitr P et al (2020) Gut microbiota profiles of treatment-na\u00efve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS ONE 15:e0236460. https:\/\/doi.org\/10.1371\/journal.pone.0236460","journal-title":"PLoS ONE"},{"key":"904_CR28","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/bloodadvances.2021006783","volume":"6","author":"A Rashidi","year":"2022","unstructured":"Rashidi A, Ebadi M, Rehman TU et al (2022) Lasting shift in the gut microbiota in patients with acute myeloid leukemia. Blood Adv 6:3451\u20133457. https:\/\/doi.org\/10.1182\/bloodadvances.2021006783","journal-title":"Blood Adv"},{"key":"904_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00661-4","volume":"14","author":"N Kapandji","year":"2025","unstructured":"Kapandji N, Salmona M, Lemoine A et al (2025) Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses. Exp Hematol Oncol 14:74. https:\/\/doi.org\/10.1186\/s40164-025-00661-4","journal-title":"Exp Hematol Oncol"},{"key":"904_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J et al (2022) Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun 13:2522. https:\/\/doi.org\/10.1038\/s41467-022-30240-8","journal-title":"Nat Commun"},{"key":"904_CR31","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41591-022-01702-9","volume":"28","author":"M Smith","year":"2022","unstructured":"Smith M, Dai A, Ghilardi G et al (2022) Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med 28:713\u2013723. https:\/\/doi.org\/10.1038\/s41591-022-01702-9","journal-title":"Nat Med"},{"key":"904_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled JU, Gomes ALC, Devlin SM et al (2020) Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N Engl J Med 382:822\u2013834. https:\/\/doi.org\/10.1056\/NEJMoa1900623","journal-title":"N Engl J Med"},{"key":"904_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1084\/jem.20112408","volume":"209","author":"RR Jenq","year":"2012","unstructured":"Jenq RR, Ubeda C, Taur Y et al (2012) Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 209:903\u2013911. https:\/\/doi.org\/10.1084\/jem.20112408","journal-title":"J Exp Med"},{"key":"904_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/CCM.0b013e3181c8fdb1","volume":"38","author":"AC Fox","year":"2010","unstructured":"Fox AC, Robertson CM, Belt B et al (2010) Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis*: Crit Care Med 38:886\u2013893. https:\/\/doi.org\/10.1097\/CCM.0b013e3181c8fdb1","journal-title":"Crit Care Med"},{"key":"904_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1641391","volume":"8","author":"C Vigneron","year":"2019","unstructured":"Vigneron C, Mirouse A, Merdji H et al (2019) Sepsis inhibits tumor growth in mice with cancer through toll-like receptor 4-associated enhanced natural killer cell activity. OncoImmunology 8:e1641391. https:\/\/doi.org\/10.1080\/2162402X.2019.1641391","journal-title":"OncoImmunology"},{"key":"904_CR36","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1164\/rccm.202004-1116TR","volume":"202","author":"A Mirouse","year":"2020","unstructured":"Mirouse A, Vigneron C, Llitjos J-F et al (2020) Sepsis and cancer: an interplay of friends and foes. Am J Respir Crit Care Med 202:1625\u20131635. https:\/\/doi.org\/10.1164\/rccm.202004-1116TR","journal-title":"Am J Respir Crit Care Med"},{"key":"904_CR37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2326-6066.CIR-15-0170","volume":"4","author":"JM Mota","year":"2016","unstructured":"Mota JM, Leite CA, Souza LE et al (2016) Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4\/CXCL12 and favors tumor progression in mice. Cancer Immunol Res 4:312\u2013322. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0170","journal-title":"Cancer Immunol Res"},{"key":"904_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956448","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang N, Lu Y, Zheng J, Liu X (2022) Of mice and men: laboratory murine models for recapitulating the immunosuppression of human sepsis. Front Immunol 13:956448. https:\/\/doi.org\/10.3389\/fimmu.2022.956448","journal-title":"Front Immunol"},{"key":"904_CR39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/cid\/ciy530","volume":"68","author":"Z Liu","year":"2019","unstructured":"Liu Z, Mahale P, Engels EA (2019) Sepsis and risk of cancer among elderly adults in the United States. Clin Infect Dis 68:717\u2013724. https:\/\/doi.org\/10.1093\/cid\/ciy530","journal-title":"Clin Infect Dis"},{"key":"904_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10040104","volume":"10","author":"B Craver","year":"2018","unstructured":"Craver B, El Alaoui K, Scherber R, Fleischman A (2018) The critical role of inflammation in the pathogenesis and progression of myeloid malignancies. Cancers 10:104. https:\/\/doi.org\/10.3390\/cancers10040104","journal-title":"Cancers"},{"key":"904_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41375-024-02136-7","volume":"38","author":"D-W Chen","year":"2024","unstructured":"Chen D-W, Fan J-M, Schrey JM et al (2024) Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche. Leukemia 38:741\u2013750. https:\/\/doi.org\/10.1038\/s41375-024-02136-7","journal-title":"Leukemia"},{"key":"904_CR42","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstr\u00f6m Smedby","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029\u20134038. https:\/\/doi.org\/10.1182\/blood-2007-10-119974","journal-title":"Blood"},{"key":"904_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ijc.24287","volume":"125","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125:398\u2013405. https:\/\/doi.org\/10.1002\/ijc.24287","journal-title":"Int J Cancer"},{"key":"904_CR44","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1182\/blood.2019000989","volume":"136","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S (2020) Clonal hematopoiesis and nonhematologic disorders. Blood 136:1606\u20131614. https:\/\/doi.org\/10.1182\/blood.2019000989","journal-title":"Blood"},{"key":"904_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1347402","volume":"14","author":"S Saluja","year":"2024","unstructured":"Saluja S, Bansal I, Bhardwaj R et al (2024) Inflammation as a driver of hematological malignancies. Front Oncol 14:1347402. https:\/\/doi.org\/10.3389\/fonc.2024.1347402","journal-title":"Front Oncol"},{"key":"904_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0883-9441(97)90030-7","volume":"12","author":"G Friedman","year":"1997","unstructured":"Friedman G, Jankowski S, Marchant A et al (1997) Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12:183\u2013187. https:\/\/doi.org\/10.1016\/s0883-9441(97)90030-7","journal-title":"J Crit Care"},{"key":"904_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ijc.28724","volume":"135","author":"KL Edlefsen","year":"2014","unstructured":"Edlefsen KL, Mart\u00ednez-Maza O, Madeleine MM et al (2014) Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype. Int J Cancer 135:913\u2013922. https:\/\/doi.org\/10.1002\/ijc.28724","journal-title":"Int J Cancer"},{"key":"904_CR48","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1182\/blood-2003-08-2860","volume":"103","author":"W Cozen","year":"2004","unstructured":"Cozen W, Gill PS, Ingles SA (2004) IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood 103:3216\u20133221. https:\/\/doi.org\/10.1182\/blood-2003-08-2860","journal-title":"Blood"},{"key":"904_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cyto.2009.12.001","volume":"50","author":"SC Sasson","year":"2010","unstructured":"Sasson SC, Smith S, Seddiki N et al (2010) IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers. Cytokine 50:58\u201368. https:\/\/doi.org\/10.1016\/j.cyto.2009.12.001","journal-title":"Cytokine"},{"key":"904_CR50","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","volume":"61","author":"B Sanchez-Correa","year":"2013","unstructured":"Sanchez-Correa B, Bergua JM, Campos C et al (2013) Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 61:885\u2013891. https:\/\/doi.org\/10.1016\/j.cyto.2012.12.023","journal-title":"Cytokine"},{"key":"904_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exphem.2023.09.002","volume":"128","author":"M Burocziova","year":"2023","unstructured":"Burocziova M, Grusanovic S, Vanickova K et al (2023) Chronic inflammation promotes cancer progression as a second hit. Exp Hematol 128:30\u201337. https:\/\/doi.org\/10.1016\/j.exphem.2023.09.002","journal-title":"Exp Hematol"},{"key":"904_CR52","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","volume":"18","author":"A Carey","year":"2017","unstructured":"Carey A, Edwards DK, Eide CA et al (2017) Identification of Interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia. Cell Rep 18:3204\u20133218. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.018","journal-title":"Cell Rep"},{"key":"904_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772408","volume":"12","author":"V Camacho","year":"2021","unstructured":"Camacho V, Kuznetsova V, Welner RS (2021) Inflammatory cytokines shape an altered immune response during myeloid malignancies. Front Immunol 12:772408. https:\/\/doi.org\/10.3389\/fimmu.2021.772408","journal-title":"Front Immunol"},{"key":"904_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccr.2013.08.019","volume":"24","author":"H-P Kuo","year":"2013","unstructured":"Kuo H-P, Wang Z, Lee D-F et al (2013) Epigenetic roles of MLL oncoproteins are dependent on NF-\u03baB. Cancer Cell 24:423\u2013437. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.019","journal-title":"Cancer Cell"},{"key":"904_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax5104","volume":"12","author":"TY Zhang","year":"2020","unstructured":"Zhang TY, Dutta R, Benard B et al (2020) IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia. Sci Transl Med 12:eaax5104. https:\/\/doi.org\/10.1126\/scitranslmed.aax5104","journal-title":"Sci Transl Med"},{"key":"904_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2016.12.011","volume":"168","author":"K Liang","year":"2017","unstructured":"Liang K, Volk AG, Haug JS et al (2017) Therapeutic targeting of MLL degradation pathways in MLL-rearranged leukemia. Cell 168:59-72.e13. https:\/\/doi.org\/10.1016\/j.cell.2016.12.011","journal-title":"Cell"},{"key":"904_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585367","volume":"11","author":"M Sezaki","year":"2020","unstructured":"Sezaki M, Hayashi Y, Wang Y et al (2020) Immuno-modulation of hematopoietic stem and progenitor cells in inflammation. Front Immunol 11:585367. https:\/\/doi.org\/10.3389\/fimmu.2020.585367","journal-title":"Front Immunol"},{"key":"904_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.it.2010.12.003","volume":"32","author":"MT Baldridge","year":"2011","unstructured":"Baldridge MT, King KY, Goodell MA (2011) Inflammatory signals regulate hematopoietic stem cells. Trends Immunol 32:57\u201365. https:\/\/doi.org\/10.1016\/j.it.2010.12.003","journal-title":"Trends Immunol"},{"key":"904_CR59","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1182\/blood-2009-04-214916","volume":"114","author":"S Rodriguez","year":"2009","unstructured":"Rodriguez S, Chora A, Goumnerov B et al (2009) Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 114:4064\u20134076. https:\/\/doi.org\/10.1182\/blood-2009-04-214916","journal-title":"Blood"},{"key":"904_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.celrep.2015.02.066","volume":"11","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Kobayashi CI, Nakamura-Ishizu A et al (2015) Bacterial c-di-GMP affects hematopoietic stem\/progenitors and their niches through STING. Cell Rep 11:71\u201384. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.066","journal-title":"Cell Rep"},{"key":"904_CR61","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15444","volume":"11","author":"Y Luo","year":"2023","unstructured":"Luo Y, Xiao J-H (2023) Inflammatory auxo-action in the stem cell division theory of cancer. PeerJ 11:e15444. https:\/\/doi.org\/10.7717\/peerj.15444","journal-title":"PeerJ"},{"key":"904_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00204","author":"LG Schuettpelz","year":"2013","unstructured":"Schuettpelz LG, Link DC (2013) Regulation of Hematopoietic Stem Cell Activity by Inflammation. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2013.00204","journal-title":"Front Immunol"},{"key":"904_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585402","volume":"11","author":"CB Johnson","year":"2020","unstructured":"Johnson CB, Zhang J, Lucas D (2020) The role of the bone marrow microenvironment in the response to infection. Front Immunol 11:585402. https:\/\/doi.org\/10.3389\/fimmu.2020.585402","journal-title":"Front Immunol"},{"key":"904_CR64","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.4049\/jimmunol.0903652","volume":"184","author":"PO Scumpia","year":"2010","unstructured":"Scumpia PO, Kelly-Scumpia KM, Delano MJ et al (2010) Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol 184:2247\u20132251. https:\/\/doi.org\/10.4049\/jimmunol.0903652","journal-title":"J Immunol"},{"key":"904_CR65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCRESAHA.118.313302","volume":"123","author":"K Vandoorne","year":"2018","unstructured":"Vandoorne K, Rohde D, Kim H-Y et al (2018) Imaging the vascular bone marrow niche during inflammatory stress. Circ Res 123:415\u2013427. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313302","journal-title":"Circ Res"},{"key":"904_CR66","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.yexcr.2016.03.006","volume":"344","author":"L Yu","year":"2016","unstructured":"Yu L, Zhao Y, Gu X et al (2016) Dual effect of LPS on murine myeloid leukemia cells: pro-proliferation and anti-proliferation. Exp Cell Res 344:210\u2013218. https:\/\/doi.org\/10.1016\/j.yexcr.2016.03.006","journal-title":"Exp Cell Res"},{"key":"904_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.617466","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Li N, Weng J, Du X (2021) Senescent mesenchymal stem cells in Myelodysplastic Syndrome: functional alterations, molecular mechanisms, and therapeutic strategies. Front Cell Dev Biol 8:617466. https:\/\/doi.org\/10.3389\/fcell.2020.617466","journal-title":"Front Cell Dev Biol"},{"key":"904_CR68","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJM199803193381205","volume":"338","author":"E Zucca","year":"1998","unstructured":"Zucca E, Bertoni F, Roggero E et al (1998) Molecular analysis of the progression from Helicobacter pylori\u2013associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 338:804\u2013810. https:\/\/doi.org\/10.1056\/NEJM199803193381205","journal-title":"N Engl J Med"},{"key":"904_CR69","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","volume":"127","author":"A Willerslev-Olsen","year":"2016","unstructured":"Willerslev-Olsen A, Krejsgaard T, Lindahl LM et al (2016) Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood 127:1287\u20131296. https:\/\/doi.org\/10.1182\/blood-2015-08-662353","journal-title":"Blood"},{"key":"904_CR70","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.semcancer.2013.09.001","volume":"23","author":"CU Niemann","year":"2013","unstructured":"Niemann CU, Wiestner A (2013) B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol 23:410\u2013421. https:\/\/doi.org\/10.1016\/j.semcancer.2013.09.001","journal-title":"Semin Cancer Biol"},{"key":"904_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00422-y","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang S-Y, Sun J-H et al (2022) Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res 9:56. https:\/\/doi.org\/10.1186\/s40779-022-00422-y","journal-title":"Mil Med Res"},{"key":"904_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J (2023) Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov 9:465. https:\/\/doi.org\/10.1038\/s41420-023-01766-7","journal-title":"Cell Death Discov"},{"key":"904_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02098-y","volume":"23","author":"J Zhang","year":"2025","unstructured":"Zhang J, Shao Y, Wu J et al (2025) Dysregulation of neutrophil in sepsis: recent insights and advances. Cell Commun Signal 23:87. https:\/\/doi.org\/10.1186\/s12964-025-02098-y","journal-title":"Cell Commun Signal"},{"key":"904_CR74","doi-asserted-by":"publisher","unstructured":"Arandi N, Dehghani M (2023) Immune Microenvironment in Hematologic Malignancies. Iran J Med Sci. https:\/\/doi.org\/10.30476\/ijms.2023.48937","DOI":"10.30476\/ijms.2023.48937"},{"key":"904_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.753677","volume":"11","author":"M Rezaei","year":"2021","unstructured":"Rezaei M, Tan J, Zeng C et al (2021) TIM-3 in leukemia; immune response and beyond. Front Oncol 11:753677. https:\/\/doi.org\/10.3389\/fonc.2021.753677","journal-title":"Front Oncol"},{"key":"904_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265255","volume":"14","author":"J Ma","year":"2023","unstructured":"Ma J, Yan S, Zhao Y et al (2023) Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells. Front Immunol 14:1265255. https:\/\/doi.org\/10.3389\/fimmu.2023.1265255","journal-title":"Front Immunol"},{"key":"904_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-023-00578-4","volume":"12","author":"TAC Snow","year":"2024","unstructured":"Snow TAC, Serisier A, Brealey D et al (2024) Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function. Intensive Care Med Exp 12:3. https:\/\/doi.org\/10.1186\/s40635-023-00578-4","journal-title":"Intensive Care Med Exp"},{"key":"904_CR78","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/path.4744","volume":"239","author":"J-F Llitjos","year":"2016","unstructured":"Llitjos J-F, Auffray C, Alby-Laurent F et al (2016) Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4: Sepsis-induced MDSC and tumour growth. J Pathol 239:473\u2013483. https:\/\/doi.org\/10.1002\/path.4744","journal-title":"J Pathol"},{"key":"904_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrc2541","volume":"9","author":"S Rakoff-Nahoum","year":"2009","unstructured":"Rakoff-Nahoum S, Medzhitov R (2009) Toll-like receptors and cancer. Nat Rev Cancer 9:57\u201363. https:\/\/doi.org\/10.1038\/nrc2541","journal-title":"Nat Rev Cancer"},{"key":"904_CR80","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","volume":"122","author":"F Mussai","year":"2013","unstructured":"Mussai F, De Santo C, Abu-Dayyeh I et al (2013) Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 122:749\u2013758. https:\/\/doi.org\/10.1182\/blood-2013-01-480129","journal-title":"Blood"},{"key":"904_CR81","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/JCI129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I (2020) Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest 130:1552\u20131564. https:\/\/doi.org\/10.1172\/JCI129204","journal-title":"J Clin Invest"},{"key":"904_CR82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1182\/bloodadvances.2021004878","volume":"6","author":"S Ragaini","year":"2022","unstructured":"Ragaini S, Wagner S, Marconi G et al (2022) An IDO1 -related immune gene signature predicts overall survival in acute myeloid leukemia. Blood Adv 6:87\u201399. https:\/\/doi.org\/10.1182\/bloodadvances.2021004878","journal-title":"Blood Adv"},{"key":"904_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/diseases10020033","volume":"10","author":"GP Barakos","year":"2022","unstructured":"Barakos GP, Hatzimichael E (2022) Microenvironmental features driving immune evasion in myelodysplastic syndromes and acute myeloid leukemia. Diseases 10:33. https:\/\/doi.org\/10.3390\/diseases10020033","journal-title":"Diseases"},{"key":"904_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050446","volume":"7","author":"J-M Forel","year":"2012","unstructured":"Forel J-M, Chiche L, Thomas G et al (2012) Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS ONE 7:e50446. https:\/\/doi.org\/10.1371\/journal.pone.0050446","journal-title":"PLoS ONE"},{"key":"904_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58662-0","volume":"16","author":"JJ Rodriguez-Sevilla","year":"2025","unstructured":"Rodriguez-Sevilla JJ, Ganan-Gomez I, Kumar B et al (2025) Natural killer cells\u2019 functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes. Nat Commun 16:3450. https:\/\/doi.org\/10.1038\/s41467-025-58662-0","journal-title":"Nat Commun"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00904-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:29:31Z","timestamp":1777357771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00904-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00904-6","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SP received a mobility research grant from l\u2019Institut Servier, outside of the submitted work. Other authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors disclose the use of ChatGPT-4o to improve the style and readability of the English manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Artificial intelligence statement"}},{"value":"Both sepsis and haematological malignancies profoundly and durably impact innate and adaptive immune responses, which may directly influence their progression.  Multiple cell types, molecular pathways, cytokines are involved and participate in the immune interplay between these two diseases.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Take-home message"}},{"value":"Sepsis and haematological malignancies profoundly impact innate and adaptive immune responses, which may influence their progression.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"A 140-character Tweet"}}],"article-number":"54"}}